US Stock MarketDetailed Quotes

FHTX Foghorn Therapeutics

Watchlist

7.620
-0.410-5.11%

Close Dec 3 16:00 ET

423.62MMarket Cap-4118P/E (TTM)

Foghorn Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

22.80%-21.01M

20.63%-25.54M

5.89%-29.35M

-161.00%-118.11M

4.78%-27.54M

-36.15%-27.21M

-10.90%-32.18M

-111.48%-31.18M

485.30%193.61M

-343.43%-28.92M

Net income from continuing operations

-33.30%-19.12M

22.07%-22.98M

17.95%-25.02M

9.60%-98.43M

16.55%-24.11M

44.33%-14.35M

-7.96%-29.49M

-13.28%-30.49M

-7.46%-108.88M

0.88%-28.89M

Operating gains losses

----

-50.00%3K

--0

----

-99.51%6K

----

Depreciation and amortization

-15.16%733K

-9.70%791K

-2.79%835K

3.91%3.45M

0.47%852K

2.49%864K

6.96%876K

5.92%859K

2.91%3.32M

4.69%848K

Other non cash items

4.53%1.39M

12.40%1.45M

18.25%1.42M

13.76%5.21M

-32.61%1.4M

411.58%1.33M

13.46%1.29M

7.72%1.2M

-0.56%4.58M

80.31%2.07M

Change In working capital

71.70%-5.23M

-12.43%-9.66M

-41.20%-9.25M

-114.87%-41.88M

-33.54%-8.24M

-1,516.23%-18.5M

-25.76%-8.59M

-102.23%-6.55M

741.92%281.55M

-117.30%-6.17M

-Change in receivables

----

--0

----

200.00%300M

--0

-Change in prepaid assets

13.41%761K

278.16%465K

49.72%1.33M

341.37%741K

59.56%-556K

-39.50%671K

-16.00%-261K

382.07%887K

83.08%-307K

35.45%-1.38M

-Change in payables and accrued expense

1,335.71%3.62M

-35.53%-1.13M

-642.33%-3.44M

-131.13%-951K

-90.87%96K

-93.05%252K

-139.54%-836K

63.57%-463K

9.58%3.06M

-55.82%1.05M

-Change in other current liabilities

6.96%-1.81M

-10.92%-2.1M

-25.54%-2.09M

-7.73%-7.51M

-20.88%-2.01M

-8.25%-1.94M

-7.24%-1.9M

4.79%-1.67M

-73.94%-6.98M

1.01%-1.66M

-Change in other working capital

55.33%-7.81M

-23.04%-6.89M

4.88%-5.05M

-140.07%-34.16M

-37.92%-5.77M

-969.65%-17.48M

-24.70%-5.6M

-35.43%-5.31M

-104.23%-14.23M

-101.24%-4.18M

Cash from discontinued investing activities

Operating cash flow

22.80%-21.01M

20.63%-25.54M

5.89%-29.35M

-161.00%-118.11M

4.78%-27.54M

-36.15%-27.21M

-10.90%-32.18M

-111.48%-31.18M

485.30%193.61M

-343.43%-28.92M

Investing cash flow

Cash flow from continuing investing activities

-259.57%-61.32M

-145.93%-17.98M

-8.17%27.1M

159.12%144.45M

674.54%37.39M

-16.56%38.43M

131.44%39.13M

118.51%29.51M

-775.43%-244.32M

-167.27%-6.51M

Net PPE purchase and sale

-281.48%-309K

96.38%-17K

84.12%-101K

-1.16%-1.22M

85.87%-38K

75.45%-81K

-28.85%-469K

-157.49%-636K

63.48%-1.21M

-236.25%-269K

Net investment purchase and sale

-258.43%-61.01M

-145.35%-17.96M

-9.77%27.2M

159.92%145.67M

699.92%37.42M

-16.98%38.51M

131.91%39.6M

118.94%30.14M

-715.69%-243.11M

-163.96%-6.24M

Cash from discontinued investing activities

Investing cash flow

-259.57%-61.32M

-145.93%-17.98M

-8.17%27.1M

159.12%144.45M

674.54%37.39M

-16.56%38.43M

131.44%39.13M

118.51%29.51M

-775.43%-244.32M

-167.27%-6.51M

Financing cash flow

Cash flow from continuing financing activities

-24.22%1.05M

100,100.00%103.21M

1,044.12%1.17M

0.85%1.78M

1,062.50%186K

316.52%1.39M

-90.00%103K

-73.44%102K

-92.14%1.76M

-99.93%16K

Net common stock issuance

--0

----

--0

----

Proceeds from stock option exercised by employees

3.89%1.44M

--0

1,044.12%1.17M

0.85%1.78M

1,062.50%186K

316.52%1.39M

-90.00%103K

-73.44%102K

24.33%1.76M

-97.84%16K

Net other financing activities

---390K

----

Cash from discontinued financing activities

Financing cash flow

-24.22%1.05M

100,100.00%103.21M

1,044.12%1.17M

0.85%1.78M

1,062.50%186K

316.52%1.39M

-90.00%103K

-73.44%102K

-92.14%1.76M

-99.93%16K

Net cash flow

Beginning cash position

136.75%140.66M

54.66%80.96M

52.15%82.04M

-47.58%53.92M

-19.39%72.01M

-5.61%59.41M

-75.69%52.35M

-47.58%53.92M

8.82%102.87M

49.96%89.34M

Current changes in cash

-744.84%-81.27M

745.28%59.69M

31.15%-1.08M

157.45%28.12M

128.32%10.03M

-52.26%12.6M

104.63%7.06M

-101.40%-1.57M

-686.82%-48.95M

-181.80%-35.42M

End cash Position

-17.54%59.39M

136.75%140.66M

54.66%80.96M

52.15%82.04M

-19.39%72.01M

-5.61%59.41M

-75.69%52.35M

-47.58%53.92M

Free cash flow

21.90%-21.31M

21.72%-25.55M

7.45%-29.45M

-162.02%-119.33M

5.53%-27.58M

-34.34%-27.29M

-11.12%-32.64M

-111.73%-31.82M

459.21%192.4M

-347.36%-29.19M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	22.80%-21.01M	20.63%-25.54M	5.89%-29.35M	-161.00%-118.11M	4.78%-27.54M	-36.15%-27.21M	-10.90%-32.18M	-111.48%-31.18M	485.30%193.61M	-343.43%-28.92M
Net income from continuing operations	-33.30%-19.12M	22.07%-22.98M	17.95%-25.02M	9.60%-98.43M	16.55%-24.11M	44.33%-14.35M	-7.96%-29.49M	-13.28%-30.49M	-7.46%-108.88M	0.88%-28.89M
Operating gains losses	----	----	----	-50.00%3K	--0	----	----	----	-99.51%6K	----
Depreciation and amortization	-15.16%733K	-9.70%791K	-2.79%835K	3.91%3.45M	0.47%852K	2.49%864K	6.96%876K	5.92%859K	2.91%3.32M	4.69%848K
Other non cash items	4.53%1.39M	12.40%1.45M	18.25%1.42M	13.76%5.21M	-32.61%1.4M	411.58%1.33M	13.46%1.29M	7.72%1.2M	-0.56%4.58M	80.31%2.07M
Change In working capital	71.70%-5.23M	-12.43%-9.66M	-41.20%-9.25M	-114.87%-41.88M	-33.54%-8.24M	-1,516.23%-18.5M	-25.76%-8.59M	-102.23%-6.55M	741.92%281.55M	-117.30%-6.17M
-Change in receivables	----	----	----	--0	----	----	----	----	200.00%300M	--0
-Change in prepaid assets	13.41%761K	278.16%465K	49.72%1.33M	341.37%741K	59.56%-556K	-39.50%671K	-16.00%-261K	382.07%887K	83.08%-307K	35.45%-1.38M
-Change in payables and accrued expense	1,335.71%3.62M	-35.53%-1.13M	-642.33%-3.44M	-131.13%-951K	-90.87%96K	-93.05%252K	-139.54%-836K	63.57%-463K	9.58%3.06M	-55.82%1.05M
-Change in other current liabilities	6.96%-1.81M	-10.92%-2.1M	-25.54%-2.09M	-7.73%-7.51M	-20.88%-2.01M	-8.25%-1.94M	-7.24%-1.9M	4.79%-1.67M	-73.94%-6.98M	1.01%-1.66M
-Change in other working capital	55.33%-7.81M	-23.04%-6.89M	4.88%-5.05M	-140.07%-34.16M	-37.92%-5.77M	-969.65%-17.48M	-24.70%-5.6M	-35.43%-5.31M	-104.23%-14.23M	-101.24%-4.18M
Cash from discontinued investing activities
Operating cash flow	22.80%-21.01M	20.63%-25.54M	5.89%-29.35M	-161.00%-118.11M	4.78%-27.54M	-36.15%-27.21M	-10.90%-32.18M	-111.48%-31.18M	485.30%193.61M	-343.43%-28.92M
Investing cash flow
Cash flow from continuing investing activities	-259.57%-61.32M	-145.93%-17.98M	-8.17%27.1M	159.12%144.45M	674.54%37.39M	-16.56%38.43M	131.44%39.13M	118.51%29.51M	-775.43%-244.32M	-167.27%-6.51M
Net PPE purchase and sale	-281.48%-309K	96.38%-17K	84.12%-101K	-1.16%-1.22M	85.87%-38K	75.45%-81K	-28.85%-469K	-157.49%-636K	63.48%-1.21M	-236.25%-269K
Net investment purchase and sale	-258.43%-61.01M	-145.35%-17.96M	-9.77%27.2M	159.92%145.67M	699.92%37.42M	-16.98%38.51M	131.91%39.6M	118.94%30.14M	-715.69%-243.11M	-163.96%-6.24M
Cash from discontinued investing activities
Investing cash flow	-259.57%-61.32M	-145.93%-17.98M	-8.17%27.1M	159.12%144.45M	674.54%37.39M	-16.56%38.43M	131.44%39.13M	118.51%29.51M	-775.43%-244.32M	-167.27%-6.51M
Financing cash flow
Cash flow from continuing financing activities	-24.22%1.05M	100,100.00%103.21M	1,044.12%1.17M	0.85%1.78M	1,062.50%186K	316.52%1.39M	-90.00%103K	-73.44%102K	-92.14%1.76M	-99.93%16K
Net common stock issuance	--0	----	----	----	----	--0	----	----	----	----
Proceeds from stock option exercised by employees	3.89%1.44M	--0	1,044.12%1.17M	0.85%1.78M	1,062.50%186K	316.52%1.39M	-90.00%103K	-73.44%102K	24.33%1.76M	-97.84%16K
Net other financing activities	---390K	----	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-24.22%1.05M	100,100.00%103.21M	1,044.12%1.17M	0.85%1.78M	1,062.50%186K	316.52%1.39M	-90.00%103K	-73.44%102K	-92.14%1.76M	-99.93%16K
Net cash flow
Beginning cash position	136.75%140.66M	54.66%80.96M	52.15%82.04M	-47.58%53.92M	-19.39%72.01M	-5.61%59.41M	-75.69%52.35M	-47.58%53.92M	8.82%102.87M	49.96%89.34M
Current changes in cash	-744.84%-81.27M	745.28%59.69M	31.15%-1.08M	157.45%28.12M	128.32%10.03M	-52.26%12.6M	104.63%7.06M	-101.40%-1.57M	-686.82%-48.95M	-181.80%-35.42M
End cash Position	-17.54%59.39M	136.75%140.66M	54.66%80.96M	52.15%82.04M	52.15%82.04M	-19.39%72.01M	-5.61%59.41M	-75.69%52.35M	-47.58%53.92M	-47.58%53.92M
Free cash flow	21.90%-21.31M	21.72%-25.55M	7.45%-29.45M	-162.02%-119.33M	5.53%-27.58M	-34.34%-27.29M	-11.12%-32.64M	-111.73%-31.82M	459.21%192.4M	-347.36%-29.19M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Heat List

Overall

No Data